Literature DB >> 22745241

Characterization and management of testicular pathology in McCune-Albright syndrome.

Alison M Boyce1, William H Chong, Thomas H Shawker, Peter A Pinto, W Marsten Linehan, Nisan Bhattacharryya, Maria J Merino, Frederick R Singer, Michael T Collins.   

Abstract

CONTEXT: The testicular phenotype in McCune-Albright syndrome (MAS) has not been well characterized. Boys present with a relatively low incidence of precocious puberty in comparison with girls. Radiographic and histological studies are limited to small series and case reports, which report testicular microlithiasis and Sertoli cell hyperplasia.
OBJECTIVE: Our objective was to characterize the biochemical, radiological, and histological spectrum and clinical management of testicular pathology in males with MAS. PATIENTS, DESIGN, AND
SETTING: Fifty-four males with MAS participated in this prospective cohort study at a clinical research center. INTERVENTION: Evaluation included testicular exam, pubertal staging, testicular ultrasound, measurement of LH, FSH, and testosterone. Orchiectomies were performed when considered clinically indicated. MAIN OUTCOME MEASURE: Prevalence and characterization of ultrasound lesions with correlation to histology were evaluated.
RESULTS: Of 54 males, 44 (81%) presented with ultrasound abnormalities including hyperechoic lesions (49%), hypoechoic lesions (30%), microlithiasis (30%), heterogeneity (47%), and focal calcifications (11%). Eight subjects underwent orchiectomy revealing large foci of Leydig cell hyperplasia, which could not be definitively distinguished from Leydig cell tumor. After no subjects developed clinical malignancy, a conservative approach was instituted, and subsequent subjects were followed with serial imaging. Testosterone and gonadotropins were normal in subjects without precocious puberty or pituitary disease. Eleven (21%) presented with precocious puberty, and a combination of aromatase inhibitors, androgen receptor blockers, and leuprolide resulted in improved predicted adult height. In addition, the first cases of testicular adrenal rest and bilateral germ cell tumors in association with MAS are presented.
CONCLUSIONS: Contrary to prevailing thinking, the incidence of gonadal pathology in MAS is equal in males and females. The predominant histopathological finding was Leydig cell hyperplasia, which carries a low risk of malignant transformation and can be managed conservatively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22745241      PMCID: PMC3431566          DOI: 10.1210/jc.2012-1791

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

Review 1.  McCune-Albright syndrome.

Authors:  P P Feuillan
Journal:  Curr Ther Endocrinol Metab       Date:  1997

2.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1993. A six-year-old boy with multiple bone lesions, repeated fractures, and sexual precocity.

Authors: 
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

3.  Endocrine investigations in two cases of feminizing Leydig cell tumour.

Authors:  P Valensi; C Coussieu; J L Kemeny; J R Attali; J Amouroux; J Sebaoun
Journal:  Acta Endocrinol (Copenh)       Date:  1987-07

4.  Testicular microlithiasis: an unreported feature of McCune-Albright syndrome in males.

Authors:  Malgorzata Wasniewska; Filippo De Luca; Silvano Bertelloni; Patrizia Matarazzo; Giovanna Weber; Giuseppe Crisafulli; Mariella Valenzise; Roberto Lala
Journal:  J Pediatr       Date:  2004-11       Impact factor: 4.406

Review 5.  Functional and clinical consequences of mutations in the FSH receptor.

Authors:  J Gromoll; M Simoni; V Nordhoff; H M Behre; C De Geyter; E Nieschlag
Journal:  Mol Cell Endocrinol       Date:  1996-12-20       Impact factor: 4.102

6.  Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.

Authors:  M C Fragoso; A C Latronico; F M Carvalho; M C Zerbini; J A Marcondes; L M Araujo; V S Lando; E T Frazzatto; B B Mendonca; S M Villares
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

7.  Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor.

Authors:  M M Martin; S M Wu; A L Martin; O M Rennert; W Y Chan
Journal:  Eur J Endocrinol       Date:  1998-07       Impact factor: 6.664

8.  Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors.

Authors:  J C Cheville; T J Sebo; D J Lager; D G Bostwick; G M Farrow
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

9.  Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.

Authors:  L S Weinstein; A Shenker; P V Gejman; M J Merino; E Friedman; A M Spiegel
Journal:  N Engl J Med       Date:  1991-12-12       Impact factor: 91.245

10.  Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.

Authors:  E W Leschek; J Jones; K M Barnes; S C Hill; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

View more
  25 in total

Review 1.  Treatment of Peripheral Precocious Puberty.

Authors:  Melissa Schoelwer; Erica A Eugster
Journal:  Endocr Dev       Date:  2015-12-17

2.  Testicular microlithiasis imaging and follow-up: guidelines of the ESUR scrotal imaging subcommittee.

Authors:  Jonathan Richenberg; Jane Belfield; Parvati Ramchandani; Laurence Rocher; Simon Freeman; Athina C Tsili; Faye Cuthbert; Michal Studniarek; Michele Bertolotto; Ahmet Tuncay Turgut; Vikram Dogra; Lorenzo E Derchi
Journal:  Eur Radiol       Date:  2014-10-15       Impact factor: 5.315

Review 3.  Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.

Authors:  Cemre Robinson; Michael T Collins; Alison M Boyce
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 4.  Fibrous dysplasia of bone: craniofacial and dental implications.

Authors:  A B Burke; M T Collins; A M Boyce
Journal:  Oral Dis       Date:  2016-09-01       Impact factor: 3.511

5.  Increased Prevalence of Malignancies in Fibrous Dysplasia/McCune-Albright Syndrome (FD/MAS): Data from a National Referral Center and the Dutch National Pathology Registry (PALGA).

Authors:  M Hagelstein-Rotman; M E Meier; B C J Majoor; A H G Cleven; P D S Dijkstra; N A T Hamdy; M A J van de Sande; O M Dekkers; N M Appelman-Dijkstra
Journal:  Calcif Tissue Int       Date:  2020-11-23       Impact factor: 4.333

6.  Treatment of Girls and Boys with McCune-Albright Syndrome with Precocious Puberty - Update 2017.

Authors:  Anna Neyman; Erica A Eugster
Journal:  Pediatr Endocrinol Rev       Date:  2017-12

7.  McCune-Albright syndrome confirmed by 99mTc-MDP.

Authors:  Ruiguo Zhang; Peng Wang; Yue Wang; Zhaowei Meng; Qiang Jia; Kunling Wang; Qian Xiao; Cailan Wu; Jian Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-13       Impact factor: 9.236

Review 8.  Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.

Authors:  Iris Hartley; Maria Zhadina; Micheal T Collins; Alison M Boyce
Journal:  Calcif Tissue Int       Date:  2019-04-29       Impact factor: 4.333

Review 9.  Diagnosis and management of precocious sexual maturation: an updated review.

Authors:  Amanda Veiga Cheuiche; Leticia Guimarães da Silveira; Leila Cristina Pedroso de Paula; Iara Regina Siqueira Lucena; Sandra Pinho Silveiro
Journal:  Eur J Pediatr       Date:  2021-03-21       Impact factor: 3.183

Review 10.  DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.

Authors:  Luis F de Castro; Diana Ovejero; Alison M Boyce
Journal:  Eur J Endocrinol       Date:  2020-05       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.